Page last updated: 2024-10-30

lobenzarit and Cancer of Prostate

lobenzarit has been researched along with Cancer of Prostate in 1 studies

lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"PBRM1 is a tumor promoter in prostate cancer, contributing to migratory and immunosuppressive phenotypes."1.72Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening. ( Blau, ME; Bursch, KL; Dykhuizen, EC; Fenske, TG; Goetz, CJ; Jensen, DR; Nuñez, R; Olp, MD; Ordonez-Rubiano, SC; Peterson, FC; Roach, MK; Shishodia, S; Smith, BC; Strohmier, BP; Volkman, BF, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shishodia, S1
Nuñez, R1
Strohmier, BP1
Bursch, KL1
Goetz, CJ1
Olp, MD1
Jensen, DR1
Fenske, TG1
Ordonez-Rubiano, SC1
Blau, ME1
Roach, MK1
Peterson, FC1
Volkman, BF1
Dykhuizen, EC1
Smith, BC1

Other Studies

1 other study available for lobenzarit and Cancer of Prostate

ArticleYear
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.
    Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

    Topics: Carcinogens; Chromatin; DNA Helicases; DNA-Binding Proteins; Histones; Humans; Male; Nuclear Protein

2022